Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AADI Aadi Biosciences
12.477-0.073-0.58%
Trading Session
01/31 12:50 ET
High
12.740
Open
12.700
Turnover
232.88K
Low
12.460
Pre Close
12.550
Volume
18.47K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Short Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Declines By 11.9%
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totalling 1,040,000 shares, a drop
5 Value Stocks In The Healthcare Sector
Understanding Value StocksA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indica
Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Significant Growth in Short Interest
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) was the target of a significant increase in short interest in the month of December. As of December 30th, there was short interest totalling 1,180,000
Piper Recommends 'Down Market Cap' Biotech Exposure for 2023
5 Value Stocks To Watch In The Healthcare Sector
What are Value Stocks?A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors ar
Aadi Bioscience, Inc. (NASDAQ:AADI) Position Raised by Point72 Asset Management L.P.
Point72 Asset Management L.P. increased its position in shares of Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) by 156.2% during the 2nd quarter, according to the company in its most recent Form
Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting
Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting
Aadi Bioscience Reports Q3 EPS (68c), Consensus (74c)
Aadi Bioscience GAAP EPS of -$0.68, Revenue of $4.24M
Aadi Bioscience Q3 FYARRO Net PRoduct Sales $4.2M, Up 24% QoQ
Aadi Bioscience Q3 FYARRO Net PRoduct Sales $4.2M, Up 24% QoQ
